Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Osteosarcoma × Docetaxel × Clear all

Phase

Status

Completed 4 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 65 Prostatic Neoplasms 48 Breast Neoplasms 45 Lung Neoplasms 25 Neoplasms 16 Neoplasm Metastasis 15 Stomach Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 9 Head and Neck Neoplasms 9 Ovarian Neoplasms 7 Sarcoma 6 Recurrence 6 Pancreatic Neoplasms 6 Esophageal Neoplasms 6 Adenocarcinoma of Lung 6 Carcinoma, Transitional Cell 5 Colorectal Neoplasms 4 Carcinoma, Squamous Cell 4 Carcinoma, Ovarian Epithelial 4 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Advanced Non-Small Cell Lung Cancer 3 Solid Tumor 2 Small Cell Lung Carcinoma 2 Inflammatory Breast Neoplasms 2 Hormone Refractory Prostate Cancer 2 HER2-positive Breast Cancer 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Cardiotoxicity 2

Interventions

Ifosfamide 5 Leucovorin 4 Doxorubicin 4 Dexrazoxane 4 Cisplatin 4 Filgrastim 3 mifamurtide 2 Neoadjuvant Therapy 2 Methotrexate 2 Mesna 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Cryosurgery 2 Chemotherapy, Adjuvant 2 Carboplatin 2 temsirolimus 1 sintilimab 1 sargramostim 1 saracatinib 1 samarium Sm-153 lexidronam 1 robatumumab 1 pembrolizumab 1 pegfilgrastim 1 pazopanib 1 niraparib 1 lexatumumab 1 glucarpidase 1 eltrombopag 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02718482 2019-05-13

OsteoREC2015

Italian Sarcoma Group

Phase 2 Terminated

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡